These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11495378)

  • 1. Health technology assessment in the area of prevention: selected screening cases in Greece.
    Mousiama T; Loakimidou S; Largatzi E; Kaitelidou D; Liaropoulus L
    Int J Technol Assess Health Care; 2001; 17(3):338-57. PubMed ID: 11495378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment and screening in The Netherlands: case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy.
    Banta HD; Oortwiin W
    Int J Technol Assess Health Care; 2001; 17(3):369-79. PubMed ID: 11495380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of health technology assessment on preventive screening in Belgium: case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy.
    Vermeulen V; Coppens K; Kesteloot K
    Int J Technol Assess Health Care; 2001; 17(3):316-28. PubMed ID: 11495376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based screening in the United Kingdom.
    Gray JA
    Int J Technol Assess Health Care; 2001; 17(3):400-8. PubMed ID: 11495383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of preventive technologies in Germany: case studies of mammography, prostate cancer screening, and fetal ultrasound.
    Perleth M; Busse R; Gibis B; Brand A
    Int J Technol Assess Health Care; 2001; 17(3):329-37. PubMed ID: 11495377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment and screening in Sweden.
    Jonsson E; Banta HD; Schersten T
    Int J Technol Assess Health Care; 2001; 17(3):380-8. PubMed ID: 11495381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography, routine ultrasonography in pregnancy, and PSA screenings in Italy.
    Favaretti C; De Pieri P
    Int J Technol Assess Health Care; 2001; 17(3):358-68. PubMed ID: 11495379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment of three screening methods in Switzerland.
    Faisst K; Schilling J; Koch P
    Int J Technol Assess Health Care; 2001; 17(3):389-99. PubMed ID: 11495382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening in Austria: the cases of mammography, PSA testing, and routine use of ultrasound in pregnancy.
    Wild C
    Int J Technol Assess Health Care; 2001; 17(3):305-15. PubMed ID: 11495375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health policy, health technology assessment, and screening in Europe.
    Banta HD
    Int J Technol Assess Health Care; 2001; 17(3):409-17. PubMed ID: 11495384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accuracy and effectiveness of routine population screening with mammography, prostate-specific antigen, and prenatal ultrasound: a review of published scientific evidence.
    Woolf SH
    Int J Technol Assess Health Care; 2001; 17(3):275-304. PubMed ID: 11495374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.
    Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L
    Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention.
    Eur J Cancer; 2000 Aug; 36(12):1473-8. PubMed ID: 10930794
    [No Abstract]   [Full Text] [Related]  

  • 14. Recommendations from the BC Office of Health Technology Assessment.
    Bassett K
    Can J Oncol; 1994 Nov; 4 Suppl 1():86-8; discussion 89-95. PubMed ID: 8853499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
    Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
    Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment and implications for clinical practice: the case of prostate cancer screening.
    Norderhaug IN; Sandberg S; Fosså SD; Forland F; Malde K; Kvinnsland S; Traaholt I; Rossiné BK; Førde OH
    Scand J Clin Lab Invest; 2003; 63(5):331-8. PubMed ID: 14599155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of cancer screening in primary care from 2005 to 2010.
    Martires KJ; Kurlander DE; Minwell GJ; Dahms EB; Bordeaux JS
    Cancer; 2014 Jan; 120(2):253-61. PubMed ID: 24166081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction: mass screening, health technology assessment, and health policy in some European countries.
    Oortwijn W; Banta HD; Cranovsky R
    Int J Technol Assess Health Care; 2001; 17(3):269-74. PubMed ID: 11495373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek view.
    Deliveliotis C; Alivizatos G; Karayiannis A; Kontothanasis D; Makrychoritis K; Lysiotis P; Dimopoulos MA
    Br J Urol; 1995 May; 75(5):637-41. PubMed ID: 7542133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.